China's Shanghai Pharma Raises Estimate Of IPO Value To $2.26 Billion
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceutical's estimate of the value of its initial public offering on the Hong Kong Stock Exchange has increased to $2.26 billion